Sarah Doffman
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Antifungal resistance and susceptibility, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Fungal Infections and Studies, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → The effect ofPseudomonas aeruginosaon pulmonary function in patients with bronchiectasis(2006)188 cited
- → Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking(2004)161 cited
- → Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease(2010)121 cited
- → Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR(2006)103 cited
- → Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients(2009)85 cited
- → Telemedicine for multidisciplinary lung cancer meetings(2004)67 cited
- → Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis(2012)44 cited
- → A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4(2025)36 cited
- → Interstitial Lung Disease in HIV(2013)31 cited
- → Invasive pulmonary aspergillosis(2005)18 cited